New breast cancer stem cell clues may help develop therapeutics

Researchers have identified a new regulatory pathway that may play an important role in basal-like breast cancer, a particularly aggressive form of breast cancer often referred to as 'triple negative.' This pathway may serve as a target for the development of an effective therapeutic.